No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Aged
-
Alemtuzumab
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm / adverse effects
-
Antibodies, Neoplasm / therapeutic use*
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Female
-
Humans
-
Lymphohistiocytosis, Hemophagocytic / chemically induced
-
Lymphohistiocytosis, Hemophagocytic / drug therapy*
-
Lymphohistiocytosis, Hemophagocytic / surgery
-
Male
-
Middle Aged
-
Stem Cell Transplantation
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm
-
Antineoplastic Agents
-
Alemtuzumab